Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.7, 2010-05, pp. : 1147-1157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estradiol Valerate/Dienogest: In Oral Contraception

By Hoy Sheridan M. Scott Lesley J.

Drugs, Vol. 69, Iss. 12, 2009-08 ,pp. : 1635-1646

Adis International

Access to resources Recommend Favorite

Estradiol Valerate/Dienogest

By Wellington K. Perry C.M.

Drugs, Vol. 62, Iss. 3, 2002-01 ,pp. : 491-504

Adis International

Access to resources Recommend Favorite

Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive: A Randomized, Open-Label, Single-Centre Study

By Junge Wolfgang

Clinical Drug Investigation, Vol. 31, Iss. 8, 2011-08 ,pp. : 573-584

Adis International

Access to resources Recommend Favorite

Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive: An Open-Label, Randomized, Crossover Study of Estradiol Valerate/Dienogest versus Ethinylestradiol/Levonorgestrel

By Klipping Christine

Drugs in R&D, Vol. 11, Iss. 2, 2011-06 ,pp. : 159-170

Adis International

Access to resources Recommend Favorite

Estradiol valerate/dienogest effective in menopausal syndrome

Inpharma, Vol. 1, Iss. 1251, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite